Back

Paradigm shifts in HFrEF management: SGLT2-Inhibitors.

3 December 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Paradigm shifts in HFrEF management: SGLT2-Inhibitors Chronic Heart Failure Open Access ESC Asia with APSC & AFC 2020

1 More presentation in this session

Presentation thumbnail
Q&A - Paradigm shifts in HFrEF management: SGLT2-Inhibitors.
Professor C. Chiang (Taipei, TW) Associate Professor J. Tan (Singapore, SG)
Video

Access the full session

Session thumbnail
Paradigm shifts in HFrEF management: SGLT2-Inhibitors
Video

The Event

Event poster

ESC Asia with APSC & AFC 2020

3 December - 5 December 2020
You may be interested in
thumbnail
Congress Presentation
Clinical characteristics and long-term prognosis of patients with heart failure with reduced, mildly reduced, and preserved left ventricular ejection fraction secondary to Chagas cardiomyopathy
thumbnail
Congress Presentation
Presence of heart failure in pts with coronary artery disease and artery hypertension
thumbnail
Congress Presentation
Non-conventional parameters from holter ECG: a promising tool for heart failure risk stratification

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources